El tratamiento con quimioterapia hoy en pacientes HER2 negativo: el papel de la eribulina - page 35

Real World Experience in TNBC presented
at SABCS 2016
‚
‚
Table 1
‚
‚
‚
`
`
‚
Table 2
‚
‚
‚
‚
Table 3
‚
‚
‚
Figure 2
R
‚
A
ectual property of the author/presenter. Contact
Ronda Copher
at (e-mail:
) for permission to reprint and /or distribute.
All TNMBC Early eribulin
(LOT1/2)
Late eribulin
(LOT 3)
†
‚
`
`
‚ ‚
‚ ‚
‚
‚
‚
Table 3. Duration of tr eatment, response and rationale for tr eatment discontinuation for
eribulin therapy by timing of eribulin initiation
1...,25,26,27,28,29,30,31,32,33,34 36,37,38,39,40,41,42,43
Powered by FlippingBook